5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.10▼ | 7.09▼ | 7.09▼ | 7.34▼ | 7.68▼ |
MA10 | 7.09▼ | 7.11▼ | 7.11▼ | 7.45▼ | 7.82▼ |
MA20 | 7.10▼ | 7.12▼ | 7.27▼ | 7.59▼ | 7.48▼ |
MA50 | 7.12▼ | 7.33▼ | 7.39▼ | 7.89▼ | 8.59▼ |
MA100 | 7.15▼ | 7.40▼ | 7.47▼ | 7.39▼ | 11.59▼ |
MA200 | 7.34▼ | 7.50▼ | 7.61▼ | 8.43▼ | 18.38▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.007▲ | -0.014▼ | -0.041▼ | 0.046▲ |
RSI | 40.791▼ | 38.472▼ | 36.298▼ | 40.582▼ | 43.119▼ |
STOCH | 37.631 | 27.685 | 24.723 | 31.766 | 25.966 |
WILL %R | -87.500▼ | -69.231 | -83.673▼ | -92.382▼ | -77.374▼ |
CCI | -120.742▼ | -54.738 | -73.684 | -220.869▼ | -90.892 |
Thursday, August 14, 2025 03:34 AM
Cybin ( ($TSE:CYBN) ) just unveiled an update. On August 13, 2025, Cybin Inc. released its unaudited condensed interim consolidated financial ...
|
Wednesday, August 13, 2025 02:39 PM
Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new ...
|
Wednesday, August 06, 2025 11:55 AM
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage neuropsychiatry company developing next-generation mental health treatments, announced ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 7.16 | 7.23 | 6.99 | 7.06 | 431,185 |
14/08/25 | 7.50 | 7.5657 | 7.04 | 7.17 | 471,407 |
13/08/25 | 7.72 | 7.75 | 7.41 | 7.60 | 414,994 |
12/08/25 | 7.25 | 7.68 | 7.2202 | 7.63 | 324,447 |
11/08/25 | 7.59 | 7.59 | 7.26 | 7.26 | 228,963 |
08/08/25 | 7.63 | 7.65 | 7.40 | 7.45 | 254,577 |
07/08/25 | 7.55 | 7.6427 | 7.4042 | 7.59 | 265,922 |
06/08/25 | 7.54 | 7.655 | 7.37 | 7.46 | 237,583 |
05/08/25 | 7.80 | 7.80 | 7.50 | 7.57 | 157,955 |
04/08/25 | 7.59 | 7.75 | 7.4133 | 7.68 | 236,873 |
|
|
||||
|
|
||||
|
|